The Rational Design and Development of A Dual Chamber Vaginal/Rectal Microbicide Gel Formulation for HIV Prevention

The DuoGel™ was developed for safe and effective dual chamber administration of antiretroviral drugs to reduce the high incidence of HIV transmission during receptive vaginal and anal intercourse. The DuoGel™s containing IQP-0528, a non-nucleoside reverse transcriptase inhibitor (NNRTI), were formul...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antiviral Res
Glavni autori: Ham, Anthony S., Nugent, Sean T., Peters, Jennifer J., Katz, David F., Shelter, Cory M., Dezzutti, Charlene S., Boczar, Ashlee D., Buckheit, Karen W., Buckheit, Robert W.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492852/
https://ncbi.nlm.nih.gov/pubmed/26093158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.06.010
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items